Lipocine Inc. (LPCN)
NASDAQ·Healthcare·Biotechnology
$2.09
-2.34%
Mkt Cap $43.75M
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (3 analysts)
$10.50
Range $6.00 – $15.00
Implied Upside
+402.4%
Consensus $10.50 vs current $2.09
NASDAQ·Healthcare·Biotechnology
$2.09
-2.34%
Mkt Cap $43.75M
Buy
0
Hold
1
Sell
0
Price Target (3 analysts)
$10.50
Range $6.00 – $15.00
+402.4%
Consensus $10.50 vs current $2.09